Abstract
Last month's announcement of the availability of genetic data from the National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III) came as welcome news to researchers looking for nationally representative data. The degree to which this information will ultimately guide treatment for substance use disorders (SUDs) remains largely unclear, given the relatively small effect of most of the currently known genotypes that influence addiction.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
